Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Galanthamine derivatives for treatment of alzheimer's disease

Galanthamine derivatives for treatment of alzheimer's disease

US Patent 6319919 · Granted Nov 20, 2001

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Clearance of amyloid beta2022
Treatment of autism2020
Tamandarin analogs and fragments thereof and methods of making and using2011
Dosage formulations for acetylcholinesterase inhibitors2011
Didemnin analogs and fragments and methods of making and using them2010
Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-contai2010
Didemnin analogs and fragments and methods of making and using them2006
Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-contai2006
Analogs of galanthamine and lycoramine as modulators of nicotinic receptors2003
Compounds for the treatment of alzheimer's disease2003
Compounds for the treatment of alzheimer's disease2003
Didemnin analogs and fragments and methods of making and using them2003